To minimize the risk of FDA scrutiny, clinical laboratories and their partners must comply with applicable device regulations by ensuring, among other things, that: the specimen collection devices included in the kit are obtained from FDA-registered manufacturers and, if applicable, are FDA-cleared or -approved
The researchers behind the phase 2 trial specifically designed the titration schedule to prevent this, and the data validated their approach
10.1016/j.ijbiomac.2015.08.022 42
These changes create a dangerous loop
Glycemic control and type 2 diabetes: CagriSema has the more extensive diabetes-specific trial data (REIMAGINE program), with demonstrated superiority over semaglutide alone on both HbA1c reduction and weight loss in T2D populations
If they dodge the question, ask again before paying